110 related articles for article (PubMed ID: 22876692)
1. [Effects of "attenuation and synergia" for Bushenhuoxue Granules on Parkinson's patients].
Li M; Yang MH; Liu Y
Zhong Yao Cai; 2012 Mar; 35(3):503-6. PubMed ID: 22876692
[TBL] [Abstract][Full Text] [Related]
2. [Effects of bushenhuoxue granules on sleep quality in Parkinson's patients].
Li M; Yang MH; Li SD; Liu Y
Zhong Yao Cai; 2011 Sep; 34(9):1473-7. PubMed ID: 22260015
[TBL] [Abstract][Full Text] [Related]
3. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
Dessibourg CA; Gachoud JP
Praxis (Bern 1994); 1995 Oct; 84(43):1235-8. PubMed ID: 7481341
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Bushen Huoxue Granule on motor function in patients with Parkinson's disease: a multicenter, randomized, double-blind and placebo-controlled trial].
Yang MH; Li M; Dou YQ; Liu Y; Luo XD; Chen JZ; Shi HJ
Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):231-7. PubMed ID: 20226144
[TBL] [Abstract][Full Text] [Related]
5. [Efficiency of new forms of madopar in Parkinson's disease].
Vendrova MI; Sadekov RA; Golubev VL
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):46-8. PubMed ID: 11195538
[TBL] [Abstract][Full Text] [Related]
6. A comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early-morning disability in Parkinson's disease. The U.K. Madopar CR Study Group.
Clin Neuropharmacol; 1989 Dec; 12(6):498-505. PubMed ID: 2691069
[TBL] [Abstract][Full Text] [Related]
7. The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia.
Guo G; Xu S; Cao LD; Wu QY
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2409-12. PubMed ID: 27338068
[TBL] [Abstract][Full Text] [Related]
8. Treatment of early Parkinson's disease with controlled-release levodopa preparations.
Rinne UK; Rinne JO
Neurology; 1989 Nov; 39(11 Suppl 2):78-81; discussion 95. PubMed ID: 2586766
[TBL] [Abstract][Full Text] [Related]
9. Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
Marion MH; Stocchi F; Quinn NP; Jenner P; Marsden CD
Adv Neurol; 1987; 45():493-6. PubMed ID: 3548262
[No Abstract] [Full Text] [Related]
10. Madopar HBS (hydrodynamically balanced system) in the treatment of Parkinson's disease.
Lees AJ
Adv Neurol; 1990; 53():475-82. PubMed ID: 2239487
[No Abstract] [Full Text] [Related]
11. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
Ondo WG; Shinawi L; Moore S
Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W
Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
[TBL] [Abstract][Full Text] [Related]
13. [Effect of TCM treatment according to syndrome differentiation in enhancing curative effect and reducing side-effect of madopa].
Lian XF; Luo XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Sep; 27(9):796-9. PubMed ID: 17969890
[TBL] [Abstract][Full Text] [Related]
14. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
15. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
Parkinson Study Group
Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
[TBL] [Abstract][Full Text] [Related]
16. Open study of sustained-release formulation of levodopa and benserazide in parkinsonian patients.
Kostić VS; Covicković-Sternić N
Neurologija; 1990; 39(2):99-105. PubMed ID: 2267052
[TBL] [Abstract][Full Text] [Related]
17. Evaluation on the efficacy and safety of Chinese herbal medication Xifeng Dingchan Pill in treating Parkinson's disease: study protocol of a multicenter, open-label, randomized active-controlled trial.
Zhang J; Ma YZ; Shen XM
J Integr Med; 2013 Jul; 11(4):285-90. PubMed ID: 23867247
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations.
Poewe WH; Lees AJ; Stern GM
Eur Neurol; 1987; 27 Suppl 1():93-7. PubMed ID: 3322842
[TBL] [Abstract][Full Text] [Related]
19. Madopar HBS in fluctuating parkinsonian patients: two-year treatment.
Pezzoli G; Tesei S; Ferrante C; Cossutta E; Zecchinelli A; Scarlato G
Mov Disord; 1988; 3(1):37-45. PubMed ID: 3050471
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease.
De Michele G; Mengano A; Filla A; Trombetta L; Campanella G
Acta Neurol (Napoli); 1989 Dec; 11(6):408-14. PubMed ID: 2694799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
